بدائل البحث:
significantly increased » significant increase (توسيع البحث)
increased decrease » increased release (توسيع البحث), increased crash (توسيع البحث)
greater decrease » greatest decrease (توسيع البحث), greater increase (توسيع البحث), greater disease (توسيع البحث)
teer decrease » mean decrease (توسيع البحث)
significantly increased » significant increase (توسيع البحث)
increased decrease » increased release (توسيع البحث), increased crash (توسيع البحث)
greater decrease » greatest decrease (توسيع البحث), greater increase (توسيع البحث), greater disease (توسيع البحث)
teer decrease » mean decrease (توسيع البحث)
-
1041
-
1042
-
1043
-
1044
-
1045
-
1046
-
1047
-
1048
-
1049
-
1050
-
1051
-
1052
-
1053
-
1054
-
1055
-
1056
-
1057
Decreased childhood asthma hospitalizations linked to hotter, drier climate with lower wind speed in drylands
منشور في 2025"…A generalized additive model analyzed the association between these trends, and the Mann-Kendall test determined if trends were increasing, decreasing, or not significant. Thirteen municipalities showed a significant link between hospitalizations and climate variables, especially wind speed, maximum temperature, and humidity. …"
-
1058
Summary of study eligibility criteria.
منشور في 2025"…Considering the high prevalence of BV among African, Caribbean and Black (ACB) women, we conducted a prospective, randomized, open-label phase 1 clinical trial to determine the feasibility, safety and tolerability of administering low-dose estrogen, probiotics or both in combination to improve vaginal health and decrease HIV-1 susceptibility.</p><p>Methods</p><p>ACB women aged 18–49 from the Greater Toronto Area (GTA) were randomized to one of four study arms: intravaginal estradiol (Estring©; 7.5mg/day); a vaginal probiotic (RepHresh™ Pro-B™) administered twice daily; a combination of Estring© and vaginal RepHresh™ Pro-B™ (twice daily); or the Estring© and oral RepHresh™ Pro-B™ (twice daily), for a duration of 30 days. …"
-
1059
Summary of study participation and feasibility.
منشور في 2025"…Considering the high prevalence of BV among African, Caribbean and Black (ACB) women, we conducted a prospective, randomized, open-label phase 1 clinical trial to determine the feasibility, safety and tolerability of administering low-dose estrogen, probiotics or both in combination to improve vaginal health and decrease HIV-1 susceptibility.</p><p>Methods</p><p>ACB women aged 18–49 from the Greater Toronto Area (GTA) were randomized to one of four study arms: intravaginal estradiol (Estring©; 7.5mg/day); a vaginal probiotic (RepHresh™ Pro-B™) administered twice daily; a combination of Estring© and vaginal RepHresh™ Pro-B™ (twice daily); or the Estring© and oral RepHresh™ Pro-B™ (twice daily), for a duration of 30 days. …"
-
1060
TBSS results showing significant AxD and RD changes at baseline and the follow-up.
منشور في 2025"…<p>The regions indicated in green represent the mean white matter skeleton, whereas the regions indicated in red represent the regions with increased AxD (first row) and RD (second row). The decreased diffusivity metrics (AxD and RD) exhibited no statistically significant differences at <i><i>P</i></i> < 0.05 after correcting for multiple comparisons (FWE). …"